期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Detection of autoantibodies in the serum of primary hepatocarcinoma patients 被引量:1
1
作者 Fang Fang hua-liang wang +4 位作者 Ping Ye Hai-Lin Deng Gui-Ling Dong Li-Ling Ma Jian wang From the Department of Clinical Laboratory, Shanghai Eastern Hepatobiliary Hospital, Shanghai 200418, China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2002年第1期94-95,共2页
Objective: To study the significance of detecting au-toantibodies in primary hepatocarcinoma(PHC) pa-tients.Methods: Autoantibodies were detected by indirect im-munofluorescence assay. Antigens and antibodies ofHBV we... Objective: To study the significance of detecting au-toantibodies in primary hepatocarcinoma(PHC) pa-tients.Methods: Autoantibodies were detected by indirect im-munofluorescence assay. Antigens and antibodies ofHBV were determined by enzymeimmune assay. Antibodyto HCV IgG was detected by enzyme-linked immunoab-sorbent assay.Results: The positive rate of autoantibody was 27.3%(38/139) in 139 PHC patients. The main type of au-toantibodies in PHC was anti-nuclear antibody (36/38, 94.7%); others included anti-smooth muscle anti-body(2/38, 5.3% ), anti-mitochondria antibody(1/38, 2.6%), anti-midbody antibody (1/38, 2.6%), andanti-liver cell membrane antibody(2/38, 5.3%).Conclusions: Detecting autoantibodies in PHC patientsis of significance in studying the mechanism of au-toimmune reaction and etiology in PHC. The diversityof autoantibodies might result from a wide variety ofetiological factors involved in PHC development, andfrom a wide variety of overexpressed or mutated pro-teins involved in repeated cycles of necrosis and regen-eration in hepatocarcinoma development. 展开更多
关键词 primary hepatocarcinoma AUTOANTIBODY anti-nuclear antibody
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部